wordpress blog stats
Connect with us

Hi, what are you looking for?

Centre suspends Aarogya Setu Mitr in response to petition by chemists’ association in Delhi High Court

The central government has suspended the Aarogya Setu Mitr portal, which is linked to the Aarogya Setu app, in response to a writ petition filed by Delhi-based South Chemists & Distributors Association. This was first reported by The Print. Aarogyasetumitr is down and currently shows a 404 error.

The association had approached the court last month alleging that the website acted as a marketing tool for only e-pharmacies, and did not mention the local brick-and-mortar pharmacies. It had sought direction that the name “Aarogya Setu” not be misused to sponsor the commercial interests of “arbitrarily hand-picked entities”. It also sought immediate closure of the website.

Aarogya Setu Mitr (see an archived version here) is a website that aggregates services providing delivery of medicines COVID-19 teleconsultations, home sample collection for lab tests. Online medicine delivery was offered by existing e-pharmacy platforms such as 1mg, NetMeds, PharmEasy, and MedLife. It is a public-private partnership between the the government’s Principal Scientific Advisor and NITI Aayog, with “voluntary participation” from organisations, industry coalitions, and startups.

The rules framed under the Drugs and Cosmetics Act, 1940, which regulates the sale of all medicines in the country, do not have a provision that allows online sale of medicines. Draft rules allowing this have remained in limbo since August 2018.

The chemists association has previously gone to court against several online pharmacies, including 1mg, opposing their functioning in the absence of a law. Their petition was later combined with a similar petition by Delhi-based Dr Zaheer Ahmed. The court had even placed a interim ban on online sale of medicines in December 2018, but this was never implemented. Proceedings for a contempt petition filed by Dr Ahmed last year are still ongoing in the Delhi HC.

Advertisement. Scroll to continue reading.

On March 26, the government allowed all licensed pharmacies to deliver medicines at doorstep, invoking a provision of the Act that empowers the government to regulate sale or distribution of any drugs essential during an epidemic or natural calamity.

Written By

I cover health, policy issues such as intermediary liability, data governance, internet shutdowns, and more. Hit me up for tips.

MediaNama’s mission is to help build a digital ecosystem which is open, fair, global and competitive.

Views

News

Looking at the definition of health data, it is difficult to verify whether health IDs are covered by the Bill.

News

The accession to the Convention brings many advantages, but it could complicate the Brazilian stance at the BRICS and UN levels.

News

In light of the state's emerging digital healthcare apparatus, how does Clause 12 alter the consent and purpose limitation model?

News

The collective implication of leaving out ‘proportionality’ from Clause 12 is to provide very wide discretionary powers to the state.

News

The latest draft is also problematic for companies or service providers that have nothing to with children's data.

You May Also Like

News

Google has released a Google Travel Trends Report which states that branded budget hotel search queries grew 179% year over year (YOY) in India, in...

Advert

135 job openings in over 60 companies are listed at our free Digital and Mobile Job Board: If you’re looking for a job, or...

News

Rajesh Kumar* doesn’t have many enemies in life. But, Uber, for which he drives a cab everyday, is starting to look like one, he...

News

By Aroon Deep and Aditya Chunduru You’re reading it here first: Twitter has complied with government requests to censor 52 tweets that mostly criticised...

MediaNama is the premier source of information and analysis on Technology Policy in India. More about MediaNama, and contact information, here.

© 2008-2021 Mixed Bag Media Pvt. Ltd. Developed By PixelVJ

Subscribe to our daily newsletter
Name:*
Your email address:*
*
Please enter all required fields Click to hide
Correct invalid entries Click to hide

© 2008-2021 Mixed Bag Media Pvt. Ltd. Developed By PixelVJ